| # | Drug | Count |
|---|---|---|
| 0 | EVOLOCUMAB | 22690 |
| 1 | ALBUTEROL SULFATE | 19096 |
| 2 | ADALIMUMAB | 12264 |
| 3 | PEGFILGRASTIM | 10265 |
| 4 | ETANERCEPT | 10153 |
| 5 | ERENUMAB-AOOE | 9519 |
| 6 | SACUBITRIL AND VALSARTAN | 7341 |
| 7 | LEUPROLIDE ACETATE | 5625 |
| 8 | ORAL SEMAGLUTIDE | 3100 |
| 9 | ACETAMINOPHEN | 3009 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGFILGRASTIM | 10265 | 0.8570 |
| 1 | ERENUMAB-AOOE | 9519 | 0.1713 |
| 2 | EVOLOCUMAB | 22690 | 0.1375 |
| 3 | ERGOCALCIFEROL | 2864 | 0.0963 |
| 4 | LEUPROLIDE ACETATE | 5625 | 0.0720 |
| 5 | CENEGERMIN-BKBJ | 949 | 0.0703 |
| 6 | ALBUTEROL SULFATE | 19096 | 0.0637 |
| 7 | SACUBITRIL AND VALSARTAN | 7341 | 0.0632 |
| 8 | ORAL SEMAGLUTIDE | 3100 | 0.0397 |
| 9 | GLYCERIN, LIDOCAINE | 540 | 0.0387 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 10676 |
| 1 | Angiotensin 2 Receptor Blocker [EPC] | 8726 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 6483 |
| 3 | GLP-1 Receptor Agonist [EPC] | 5732 |
| 4 | Corticosteroid [EPC] | 5229 |
| 5 | Insulin Analog [EPC] | 5155 |
| 6 | Benzodiazepine [EPC] | 4295 |
| 7 | Estrogen [EPC] | 3271 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 3013 |
| 9 | Proton Pump Inhibitor [EPC] | 2822 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Growth Hormone Secretagogue Receptor Agonist [EPC] | 1 | 0.2000 |
| 1 | Ectoparasiticide [EPC] | 252 | 0.0643 |
| 2 | Semifluorinated Alkane [EPC] | 94 | 0.0404 |
| 3 | mu-Opioid Receptor Agonist [EPC] | 108 | 0.0366 |
| 4 | Vasopressin V2 Receptor Antagonist [EPC] | 535 | 0.0358 |
| 5 | Opioid Antagonist [EPC] | 34 | 0.0354 |
| 6 | Cholinergic Nicotinic Agonist [EPC] | 1813 | 0.0296 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 8726 | 0.0273 |
| 8 | Insulin [EPC] | 1201 | 0.0259 |
| 9 | Parathyroid Hormone-Related Peptide Analog [EPC] | 767 | 0.0247 |